# A Study of Metformin to Improve Cardiac Function After LVAD Implantation

Study · id `cardio:ct-nct07666698` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT07666698](<https://clinicaltrials.gov/study/NCT07666698>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT07666698

Browse, organ or system: Heart  
Browse, condition area: Heart failure  

## In plain language

A phase 1/2 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 108 participants.

## Technical summary

Registry record NCT07666698. Randomized; quadruple masking; primary purpose treatment. Start 2026-07-01 (actual); primary completion 2028-07 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase: Phase 1/2
- Enrolled: 108 participants (planned count; ClinicalTrials.gov record NCT07666698, source copy `cardio:ctgov-nct07666698-2026-09-02`, retrieved 2026-10-26)
- Started: 2026-07-01 (actual) (ClinicalTrials.gov record NCT07666698, source copy `cardio:ctgov-nct07666698-2026-09-02`, retrieved 2026-10-26)
- Primary completion: 2028-07 (anticipated) (ClinicalTrials.gov record NCT07666698, source copy `cardio:ctgov-nct07666698-2026-09-02`, retrieved 2026-10-26)
- Completion: 2029-09 (anticipated) (ClinicalTrials.gov record NCT07666698, source copy `cardio:ctgov-nct07666698-2026-09-02`, retrieved 2026-10-26)
- Countries: China (ClinicalTrials.gov record NCT07666698, source copy `cardio:ctgov-nct07666698-2026-09-02`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct07666698-2026-09-02`, retrieved 2026-10-26)

## The registry's words

- Brief title: A Study of Metformin to Improve Cardiac Function After LVAD Implantation
- Condition: Heart Failure
- Condition: Left Ventricular Assist Device
- Intervention (Drug): Metformin Hydrochloride
- Intervention (Drug): Placebo
- Lead sponsor: The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Heart failure (`cardio:heart-failure`)
- Registry lists this organization as the lead sponsor: The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School (`cardio:org-the-affiliated-nanjing-drum-tower-hospital-of-nanjing-3a906f`)

## Provenance

Content hash: 38efb7b4246bfe358c2f839156fc8ed615b905033e075ea6521395fe40d512de
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
